PMID- 32526539 OWN - NLM STAT- MEDLINE DCOM- 20210322 LR - 20210322 IS - 1879-1360 (Electronic) IS - 0022-3999 (Linking) VI - 135 DP - 2020 Aug TI - The role of immune and oxidative pathways in menstrual cycle associated depressive, physio-somatic, breast and anxiety symptoms: Modulation by sex hormones. PG - 110158 LID - S0022-3999(20)30169-0 [pii] LID - 10.1016/j.jpsychores.2020.110158 [doi] AB - OBJECTIVE: To examine whether 1) immune and nitro-oxidative stress (IO&NS) biomarkers are associated with premenstrual syndrome (PMS); and 2) changes in IO&NS biomarkers during the menstrual cycle (MC) are associated with PMS symptoms and plasma estradiol and progesterone. METHODS: This longitudinal study examined 41 women who completed the Daily Record of Severity of Problems (DRSP) rating scale during 28 consecutive days and assayed plasma levels of complement C3 and C4, highly sensitive C-reactive protein (hsCRP), haptoglobin (Hp), advanced oxidation protein products (AOPP), lipid hydroperoxides (LOOH), nitric oxide metabolites (NOx), total radical-trapping antioxidant parameter (TRAP), sulfhydryl (-SH) groups and the activity of paraoxonase (PON)1 at days 7 (D7), 14 (D14), 21 (D21) and 28 (D28) of the MC. MC Associated Syndrome (MCAS) was diagnosed when the summed DRSP score during the MC is >0.666 percentile. RESULTS: All biomarkers, except hsCRP, showed significant alterations during the MC. Arylesterase (AREase) was lowered at D28, while LOOH increased at D14 and C4 at D21 in MCAS. Total DRSP scores were predicted by the combined effects of C4 (positively) and AREase and malondialdehyde (MDA) (both inversely associated). Progesterone lowered levels of LOOH, AOPP and C3 and estradiol lowered levels of Hp while both sex hormones increased 4-(chloromethyl)phenyl acetate (CMPA)ase and AREase activities and levels of -SH groups. CONCLUSION: PMS/MCAS is not accompanied by a peripheral inflammatory response. Lowered MDA and antioxidant defenses and increased C4 may play a role in MC symptoms while sex hormones may have a protective effect against oxidative stress toxicity. CI - Copyright (c) 2020 Elsevier Inc. All rights reserved. FAU - Roomruangwong, Chutima AU - Roomruangwong C AD - Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. FAU - Matsumoto, Andressa Keiko AU - Matsumoto AK AD - Health Sciences Graduate Program, Health Sciences Center, State University of Londrina, Londrina, PR, Brazil. FAU - Michelin, Ana Paula AU - Michelin AP AD - Health Sciences Graduate Program, Health Sciences Center, State University of Londrina, Londrina, PR, Brazil. FAU - de Oliveira Semeao, Laura AU - de Oliveira Semeao L AD - Health Sciences Graduate Program, Health Sciences Center, State University of Londrina, Londrina, PR, Brazil. FAU - de Lima Pedrao, Joao Victor AU - de Lima Pedrao JV AD - Health Sciences Graduate Program, Health Sciences Center, State University of Londrina, Londrina, PR, Brazil. FAU - Moreira, Estefania G AU - Moreira EG AD - Health Sciences Graduate Program, Health Sciences Center, State University of Londrina, Londrina, PR, Brazil. FAU - Sirivichayakul, Sunee AU - Sirivichayakul S AD - Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Electronic address: Sunee.S@chula.ac.th. FAU - Carvalho, Andre AU - Carvalho A AD - Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada. Electronic address: andre.carvalho@camh.ca. FAU - Barbosa, Decio S AU - Barbosa DS AD - Health Sciences Graduate Program, Health Sciences Center, State University of Londrina, Londrina, PR, Brazil. FAU - Maes, Michael AU - Maes M AD - Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Department of Psychiatry, Medical University of Plovdiv, Plovdiv, Bulgaria; IMPACT Strategic Research Center, Deakin University, Geelong, Australia. Electronic address: dr.michaelmaes@hotmail.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20200523 PL - England TA - J Psychosom Res JT - Journal of psychosomatic research JID - 0376333 RN - 0 (Biomarkers) RN - 0 (Gonadal Steroid Hormones) RN - 31C4KY9ESH (Nitric Oxide) RN - 9007-41-4 (C-Reactive Protein) SB - IM MH - Adult MH - Anxiety/complications/*metabolism/physiopathology MH - Biomarkers/blood MH - Breast/*pathology MH - C-Reactive Protein/metabolism MH - Female MH - Gonadal Steroid Hormones/*metabolism MH - Humans MH - Longitudinal Studies MH - Menstrual Cycle/*metabolism/physiology/psychology MH - Middle Aged MH - Nitric Oxide/blood MH - *Oxidative Stress OTO - NOTNLM OT - Antioxidants OT - Anxiety OT - Biomarkers OT - Depression OT - Inflammation OT - Neuro-immune OT - Oxidative stress OT - Premenstrual syndrome COIS- Declaration of Competing Interest The authors have no conflict of interest with any commercial or other association in connection with the submitted article. EDAT- 2020/06/12 06:00 MHDA- 2021/03/23 06:00 CRDT- 2020/06/12 06:00 PHST- 2020/02/24 00:00 [received] PHST- 2020/04/16 00:00 [revised] PHST- 2020/05/19 00:00 [accepted] PHST- 2020/06/12 06:00 [pubmed] PHST- 2021/03/23 06:00 [medline] PHST- 2020/06/12 06:00 [entrez] AID - S0022-3999(20)30169-0 [pii] AID - 10.1016/j.jpsychores.2020.110158 [doi] PST - ppublish SO - J Psychosom Res. 2020 Aug;135:110158. doi: 10.1016/j.jpsychores.2020.110158. Epub 2020 May 23.